AARP Applauds Drug-Price Negotiation Bill
Posted on: Friday, 5 January 2007, 18:00 CST
The AARP, the United States' largest lobbying group, voiced its support for Medicare drug price negotiations Friday.
The House is currently considering a bill that would allow the secretary of Health and Human Services to negotiate with drug manufacturers to lower drug prices for the Medicare Part D drug benefit.
The bill is a common sense approach to ... develop a workable negotiation process for prescription drugs, said William Novelli, chief executive officer of the group, which boasts 38 million seniors as members.
By leveraging Medicare's significant buying power to augment the already strong foundation created by the Medicare Modernization Act, we believe the Secretary can achieve additional savings for beneficiaries, while improving the program and reducing costs for taxpayers, Novelli said.
Source: United Press International
Related Articles
- Federal Officials Unveil Companies That Can Offer Medicare Drug Coverage
- F-D-C Reports Inc. Launches Weekly Publication About Changes in Medicare Drug Marketplace
- Introducing Medicare Drug Focus: Weekly Business Intelligence for the Emerging Medicare Drug Marketplace.
- Medicare Drug Benefit Letters Due
- Bush: Monthly Premiums for New Medicare Drug Benefit to Be Less
- Introduces Medicare Drug Benefit Outlooks Reports
- AVOS Introduces Medicare Drug Benefit Outlooks Reports
- National Organizations Start Education, Ad Campaign for Medicare Drug Plan
- New Medicare Drug Law Criticized
- Groups: Medicare Drug Card Enrollment Low
 |
 |
User Comments (0)
RSS Feeds